292
Participants
Start Date
December 11, 2014
Primary Completion Date
May 25, 2016
Study Completion Date
May 25, 2016
VX-787 300 mg
A oral dose of 300 mg VX-787 tablet will be administered over 5-6 days.
VX-787 600 mg
A oral dose of VX-787 600 mg (formulated as 2\*300 mg tablets) will be administered over 5-6 days.
Oseltamivir 75 mg
A oral dose of 75 mg Oseltamivir capsule will be administered over 5-6 days.
Placebo
Subjects will receive matching placebo of Oseltamivir
Athens
Birmingham
Gulf Shores
Huntsville
Scottsboro
Harrisburg
Phoenix
Anaheim
Burbank
Canoga Park
Chula Vista
El Cajon
Encino
Fresno
Garden Grove
Harbor City
Huntington Beach
La Mesa
Lomita
Long Beach
Norwalk
Oakland
Oceanside
Paramount
San Diego
Santa Monica
Tustin
Upland
Colorado Springs
Northglenn
Washington D.C.
Boca Raton
Boynton Beach
Bradenton
Brooksville
Chiefland
Clearwater
Coral Gables
Doral
Edgewater
Fort Myers
Hialeah
Homestead
Jacksonville
Kissimmee
Lake Worth
Lakeland
Long Beach Resort
Miami
New Port Richey
North Miami Beach
Orlando
Ormond Beach
Pembroke Pines
Sarasota
St. Petersburg
Tampa
West Palm Beach
Atlanta
Columbus
Anderson
Idaho Falls
Meridian
Anderson
Muncie
Newburgh
Council Bluffs
Overland Park
Bardstown
Hazard
Eunice
Mandeville
Shreveport
Oxon Hill
Worcester
Belton
Niles
Troy
St Louis
Fremont
Las Vegas
Berlin
Brooklyn
New York
Rochester
Rosedale
Advance
Hickory
Morehead City
Morganton
Salisbury
Akron
Dayton
Hilliard
Huber Heights
Tulsa
Harleysville
Jenkintown
Philadelphia
Warminster
East Providence
Johnston
Greer
Laurens
Mt. Pleasant
Rock Hill
Simpsonville
Rapid City
Bristol
Amarillo
Arlington
Austin
Baytown
Carrollton
Corpus Christi
Dallas
Fort Worth
Houston
Humble
Katy
Plano
San Antonio
Tomball
Clinton
Salt Lake City
South Jordan
Alexandria
La Crosse
Milwaukee
Borgerhout
Linkebeek
Massemen
Wichelen
Sofia
Veliko Tarnovo
Calgary
West Vancouver
Mount Pearl
Brampton
Newmarket
Toronto
Mirabel
Montreal
Saint-Jérôme
Trois-Rivières
Paide
Saku
Tallinn
Tartu
Võru
Berlin
Essen
Goch
Hamburg
Stuhr
Balvi
Daugavpils
Jelgava
Jēkabpils
Kuldīga
Lielvārde
Riga
Toa Baja
Boksburg
Breyten
Cape Town
Durban
Johannesburg
Kempton Park
Krugersdorp
Middelburg
Moloto South
Pretoria
Thabazimbi
Vanderbijlpark
Worcester
Collaborators (1)
Janssen Pharmaceuticals
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY